Ocugen (OCGN) Common Equity (2014 - 2026)

Ocugen's Common Equity history runs 13 years deep, the most recent figure standing at $5.8 million for Q1 2026.

• Quarterly Common Equity fell 63.52% year-over-year to $5.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.8 million (down 63.52% YoY) and the FY2025 annual result came in at -$12.2 million, down 141.06% from the prior year.
• Common Equity was $5.8 million for Q1 2026 at Ocugen, up from -$12.2 million in the prior quarter.
• Across five years, Common Equity topped out at $125.5 million in Q1 2022 and bottomed at -$12.2 million in Q4 2025.
• A 5-year average of $43.5 million and a median of $40.6 million in 2023 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2022 — Common Equity jumped 169.99% — and 2025, when it tumbled 141.06%.
• Ocugen's Common Equity stood at $74.0 million in 2022, then slumped by 45.17% to $40.6 million in 2023, then retreated by 26.95% to $29.6 million in 2024, then tumbled by 141.06% to -$12.2 million in 2025, then jumped by 147.71% to $5.8 million in 2026.
• Business Quant data shows OCGN's Common Equity at $5.8 million in Q1 2026, -$12.2 million in Q4 2025, and $3.5 million in Q3 2025.